Lupin launches generic drug to control postpartum hemorrhage in US
New Delhi: Drug maker Lupin launched Methylergonovine Maleate tablets, used for prevention and control of postpartum hemorrhage, in the American market.
The company has launched the product in the US after having received approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a statement.
Lupin's product is the generic equivalent of Novartis Pharmaceuticals Corp's Methergine which is indicated for prevention and control of postpartum hemorrhage.
As per the latest industry estimates, Methylergonovine Maleate tablets had annual sales of around USD 71.5 million in the US.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd